# Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment

> **NCT01747538** · PHASE3 · TERMINATED · sponsor: **XOMA (US) LLC** · enrollment: 281 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Dose 1 gevokizumab
- **DRUG:** Dose 2 gevokizumab

## Key facts

- **NCT ID:** NCT01747538
- **Lead sponsor:** XOMA (US) LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01747538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01747538, "Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01747538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*